{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:19Z","timestamp":1792794739724,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acci\u00f3n Estrat\u00e9gica en Salud 2021"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alicante Healthcare and Biomedical Research Institute","id":[{"id":"https:\/\/ror.org\/03yr0pg70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"X Convocatoria de Ayudas para el Apoyo y Fomento de La Investigaci\u00f3n del Instituto"},{"name":"Gr\u00fcnenthal laboratories"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the inflammatory profile of asymptomatic hyperuricaemia (AH) with ultrasound evidence of monosodium urate (MSU) crystals (AH-MSUpos), vs AH without deposits (AH-MSUneg), intercritical gout and normouricaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on serum urate levels, musculoskeletal ultrasound and history of flares, we divided 122 participants into four groups: normouricaemia, AH-MSUneg, AH-MSUpos and intercritical gout. We tested four ultrasound definitions for MSU deposition in AH: grade 2\u20133 (G2\u20133) double contour and\/or tophi, G1\u20133 double contour and\/or tophi, G1\u20133 Stewart scheme (double contour sign in knee cartilage and\/or first metatarsophalangeal joint and\/or tophi in first metatarsophalangeal joint) and G2\u20133 Stewart scheme. Serum acute phase reactants, cytokines, pyroptosis derivates and neutrophil-related proteins were measured and compared between groups. A linear regression model was fitted to correlate crystal and inflammatory burden (measured by ultrasound) with inflammatory markers in hyperuricaemics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Rates of MSU deposition in AH ranged from 26.0% to 68.8%, depending on the definition used. Levels of CRP, leukocytes, IL-1RA, IL-6, sIL-6R, IL-18, TNF-\u03b1, TGF-\u03b2 and galectin-3 were higher in hyperuricaemics vs normouricaemics. Sex, obesity and comorbidity scores influenced some comparisons. We saw no differences comparing AH-MSUposvs AH-MSUneg groups, except for higher calprotectin using G1\u20133 sonographic definitions and higher CRP and TGF-\u03b2 when restricted to women and obese participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hyperuricaemia is associated with substantial inflammation and some degree of active pyroptosis. Four different ultrasound definitions for AH with MSU deposits yielded similar findings, although we noted some differences in calprotectin, CRP, and TGF-\u03b2. Sex, obesity, and comorbidities influenced some inflammatory responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae533","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:23:04Z","timestamp":1727450584000},"page":"1807-1816","source":"Crossref","is-referenced-by-count":12,"title":["Systemic inflammation in asymptomatic hyperuricaemia with sonographic crystal deposits, including a comparison with normouricaemia and gout"],"prefix":"10.1093","volume":"64","author":[{"given":"Mar\u00eda-Luisa","family":"Peral-Garrido","sequence":"first","affiliation":[{"name":"Rheumatology Section, Vinalop\u00f3 University Hospital , Elche,","place":["Spain"]},{"name":"Clinical Medicine Department, Miguel Hern\u00e1ndez University of Elche , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"G\u00f3mez-Sabater","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Dr. Balmis Alicante General University Hospital , Alicante,","place":["Spain"]},{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ca\u00f1o","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Dr. Balmis Alicante General University Hospital , Alicante,","place":["Spain"]},{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Berm\u00fadez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Dr. Balmis Alicante General University Hospital , Alicante,","place":["Spain"]},{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Boix","sequence":"additional","affiliation":[{"name":"Clinical Medicine Department, Miguel Hern\u00e1ndez University of Elche , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-3573","authenticated-orcid":false,"given":"Teresa","family":"Lozano","sequence":"additional","affiliation":[{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]},{"name":"Cardiology Service, Dr. Balmis Alicante General University Hospital , Alicant,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"S\u00e1nchez-Ortiga","sequence":"additional","affiliation":[{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]},{"name":"Endocrinology and Nutrition Service, Dr. Balmis Alicante General University Hospital , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Perdiguero","sequence":"additional","affiliation":[{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]},{"name":"Nefrology Service, Dr. Balmis Alicante General University Hospital , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Caro-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Internal Medicine Service, Hospital Sant Vicent del Raspeig-HACLE , San Vicente del Raspeig,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Primary Care, Campoamor Health Center , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Franc\u00e9s","sequence":"additional","affiliation":[{"name":"Clinical Medicine Department, Miguel Hern\u00e1ndez University of Elche , Alicante,","place":["Spain"]},{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]},{"name":"Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBEREHD) , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Pascual","sequence":"additional","affiliation":[{"name":"Clinical Medicine Department, Miguel Hern\u00e1ndez University of Elche , Alicante,","place":["Spain"]},{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0219-9055","authenticated-orcid":false,"given":"Mariano","family":"Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Clinical Medicine Department, Miguel Hern\u00e1ndez University of Elche , Alicante,","place":["Spain"]},{"name":"Rheumatology Section, Dr. Balmis Alicante General University Hospital , Alicante,","place":["Spain"]},{"name":"Research Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL) , Alicante,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2025040212124189300_keae533-B1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","volume":"78","author":"Bursill","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2025040212124189300_keae533-B3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2025040212124189300_keae533-B4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.39581","article-title":"Silent monosodium urate crystal deposits are associated with severe coronary calcification in asymptomatic hyperuricemia: an exploratory study","volume":"68","author":"Andr\u00e9s","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025040212124189300_keae533-B6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/rheumatology\/kez023","article-title":"Synovial fluid leukocyte count in asymptomatic hyperuricaemia with crystal deposition: a proof-of-concept study","volume":"58","author":"Andr\u00e9s","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212124189300_keae533-B7","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar3223","article-title":"Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study","volume":"13","author":"Pineda","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2025040212124189300_keae533-B8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","article-title":"Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B9","doi-asserted-by":"crossref","first-page":"e000593","DOI":"10.1136\/rmdopen-2017-000593","article-title":"Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT","volume":"4","author":"Wang","year":"2018","journal-title":"RMD Open"},{"key":"2025040212124189300_keae533-B10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"2025040212124189300_keae533-B11","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1093\/rheumatology\/keab335","article-title":"The inflammatory role of silent urate crystal deposition in intercritical gout","volume":"60","author":"Diaz-Torne","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212124189300_keae533-B12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/15257770802136040","article-title":"Asymptomatic hyperuricemia: impact of ultrasonography","volume":"27","author":"Puig","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2025040212124189300_keae533-B13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jdiacomp.2017.12.015","article-title":"Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia: the Fremantle Diabetes Study Phase II","volume":"32","author":"Keen","year":"2018","journal-title":"J Diabetes Complications"},{"key":"2025040212124189300_keae533-B14","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/acr.23549","article-title":"Levels of cytokines and microRNAs in individuals with asymptomatic hyperuricemia and ultrasonographic findings of gout: a bench-to-bedside approach","volume":"70","author":"Estevez-Garcia","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025040212124189300_keae533-B15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780150209","article-title":"The influence of temperature on the solubility of monosodium urate","volume":"15","author":"Loeb","year":"1972","journal-title":"Arthritis Rheum"},{"key":"2025040212124189300_keae533-B16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B17","doi-asserted-by":"crossref","first-page":"795984","DOI":"10.3389\/fmed.2021.795984","article-title":"Sonographic tophi and inflammation are associated with carotid atheroma plaques in gout","volume":"8","author":"Calabuig","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2025040212124189300_keae533-B18","doi-asserted-by":"crossref","first-page":"152470","DOI":"10.1016\/j.semarthrit.2024.152470","article-title":"Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: a comparative study","volume":"68","author":"Peral-Garrido","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212124189300_keae533-B19","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2013-203487","article-title":"Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout?","volume":"73","author":"Naredo","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semarthrit.2019.01.004","article-title":"Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: a systematic review and meta-analysis","volume":"49","author":"Stewart","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212124189300_keae533-B21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.semarthrit.2020.11.011","article-title":"Consensus-based semi-quantitative ultrasound scoring system for gout lesions: results of an OMERACT Delphi process and web-reliability exercise","volume":"51","author":"Christiansen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212124189300_keae533-B22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"2025040212124189300_keae533-B23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2020-219816","article-title":"EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)","volume":"80","author":"Costantino","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"European Heart Journal"},{"key":"2025040212124189300_keae533-B25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820139.2016.1153651","article-title":"Cytokine profile in gout: inflammation driven by IL-6 and IL-18?","volume":"45","author":"Cavalcanti","year":"2016","journal-title":"Immunol Invest"},{"key":"2025040212124189300_keae533-B26","doi-asserted-by":"crossref","first-page":"e000157","DOI":"10.1161\/JAHA.113.000157","article-title":"Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010","volume":"3","author":"Krishnan","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2025040212124189300_keae533-B27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.1780270417","article-title":"Tophaceous gout: a clinical and radiographic assessment","volume":"27","author":"Nakayama","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2025040212124189300_keae533-B28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2025040212124189300_keae533-B29","doi-asserted-by":"crossref","first-page":"12537","DOI":"10.1038\/s41598-023-39775-2","article-title":"Hyperuricemia is accompanied by elevated peripheral CD4+ T cells","volume":"13","author":"Yu","year":"2023","journal-title":"Sci Rep"},{"key":"2025040212124189300_keae533-B30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10067-023-06595-8","article-title":"Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study","volume":"42","author":"Amezcua-Guerra","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2025040212124189300_keae533-B31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4049\/jimmunol.1900228","article-title":"The pyroptotic cell death effector gasdermin D is activated by gout-associated uric acid crystals but is dispensable for cell death and IL-1\u03b2 release","volume":"203","author":"Rashidi","year":"2019","journal-title":"J Immunol"},{"key":"2025040212124189300_keae533-B32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat Med"},{"key":"2025040212124189300_keae533-B33","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/art.11079","article-title":"Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis","volume":"48","author":"Ryckman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025040212124189300_keae533-B34","doi-asserted-by":"crossref","first-page":"108826","DOI":"10.1016\/j.celrep.2021.108826","article-title":"Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis","volume":"34","author":"Phulphagar","year":"2021","journal-title":"Cell Reports"},{"key":"2025040212124189300_keae533-B35","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10096-013-1919-4","article-title":"Circulating galectin-3 in infections and non-infectious inflammatory diseases","volume":"32","author":"ten Oever","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025040212124189300_keae533-B36","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3390\/cells10112880","article-title":"Instructions for flow cytometric detection of ASC specks as a readout of inflammasome activation in human blood","volume":"10","author":"Wittmann","year":"2021","journal-title":"Cells"},{"key":"2025040212124189300_keae533-B37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13075-020-02244-6","article-title":"Neutrophil activation identifies patients with active polyarticular gout","volume":"22","author":"Vedder","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025040212124189300_keae533-B38","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/rheumatology\/keaa712","article-title":"A neutrophil signature is strongly associated with increased cardiovascular risk in gout","volume":"60","author":"Vedder","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212124189300_keae533-B39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/gucdd2020012","article-title":"Sex-specific differences in cytokine production capacity in patients with gout compared to controls","volume":"2","author":"Badii","year":"2024","journal-title":"Gout Urate Crystal Deposition Dis"},{"key":"2025040212124189300_keae533-B40","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/rheumatology\/keu174","article-title":"The effect of diet-induced obesity on the inflammatory phenotype of non-adipose-resident macrophages in an in vivo model of gout","volume":"53","author":"Shaw","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212124189300_keae533-B41","doi-asserted-by":"crossref","first-page":"105509","DOI":"10.1016\/j.jbspin.2022.105509","article-title":"Where should we set the start of gout?","volume":"90","author":"Pascual","year":"2023","journal-title":"Joint Bone Spine"},{"key":"2025040212124189300_keae533-B42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025040212124189300_keae533-B43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.0603294","article-title":"Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8\/A9 from neutrophils","volume":"76","author":"Ryckman","year":"2004","journal-title":"J Leukoc Biol"},{"key":"2025040212124189300_keae533-B44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025040212124189300_keae533-B45","first-page":"830","article-title":"Value of a short four-joint ultrasound test for gout diagnosis: a pilot study","volume":"30","author":"Peiteado","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2025040212124189300_keae533-B46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/keaa366","article-title":"Ultrasound for the diagnosis of gout\u2014the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group","volume":"60","author":"Christiansen","year":"2021","journal-title":"Rheumatology"},{"key":"2025040212124189300_keae533-B47","doi-asserted-by":"crossref","first-page":"107909","DOI":"10.1016\/j.isci.2023.107909","article-title":"Hyperuricemia remodels the serum proteome toward a higher inflammatory state","volume":"26","author":"Cab\u0103u","year":"2023","journal-title":"iScience"},{"key":"2025040212124189300_keae533-B48","first-page":"945","article-title":"Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker","volume":"83","author":"Ea","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae533\/60007288\/keae533.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1807\/60007288\/keae533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1807\/60007288\/keae533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T14:29:55Z","timestamp":1743604195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1807\/7796567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,30]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae533","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,9,30]]}}}